Fernanda Herrera

11PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2026
Molecular Profiling to Guide Fertility Sparing Therapy in Early-Stage Endometrial Cancer: A EORTC Gynaecological Cancer Group Study.

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Aug 05, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. Cancers 2024, 16, 2097.

Minna Cloître, Sofian Benkhaled, Sarah Boughdad

|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.

Susana Banerjee, Eleonora Ghisoni, Anita Wolfer

|Jun 19, 2024
Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study.

Minna Cloître, Sofian Benkhaled, Sarah Boughdad

|Jun 04, 2024
Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy.

Katiuska Passelli, David Repáraz, Remy Kinj

Pageof 2

Frequent Collaborators

4 joint publications

Dominik R Berthold

4 joint publications

John Prior

3 joint publications

Denarda Dangaj Laniti

2 joint publications

Maria Ochoa-de-Olza